Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Confirmatory Study of Substantial Equivalence Between cureVision cV and MolecuLight i:X in Detecting Bacterial Burden in Wounds

NCT07611318 is registered in ClinicalTrials.gov with Capsicure, LLC as lead sponsor.

NCT NCT07611318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07611318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Confirmatory Study of Substantial Equivalence Between cureVision cV and MolecuLight i:X in Detecting Bacterial Burden in Wounds
Lead sponsor
Capsicure, LLC
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
June 10, 2026
Completion date
October 1, 2026
Enrollment
100 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

dfu, pressure injuries, surgical wound, vlu, wounds